Literature DB >> 9179897

Ion implantation and protein coating of detachable coils for endovascular treatment of cerebral aneurysms: concepts and preliminary results in swine models.

Y Murayama1, F Viñuela, Y Suzuki, H M Do, T F Massoud, G Guglielmi, C Ji, M Iwaki, M Kusakabe, M Kamio, T Abe.   

Abstract

OBJECTIVE: Complete anatomic obliteration remains difficult to achieve with endovascular treatment of wide-necked aneurysms using Guglielmi detachable platinum coils (GDCs). Ion implantation is a physicochemical surface modification process resulting from the impingement of a high-energy ion beam. Ion implantation and protein coating were used to alter the surface properties (thrombogenicity, endothelial cellular migration, and adhesion) of GDCs. These modified coils were compared with standard GDCs in the treatment of experimental swine aneurysms.
METHODS: In an initial study, straight platinum coils were used to compare the acute thrombogenicity of standard and modified coils. Modified coils were coated with albumin, fibronectin, or collagen and underwent Ne+ ion implantation at a dose of 1 x 10(15) ions/cm2 and an energy of 150 keV. Coils were placed in common iliac arteries of 17 swine for 1 hour, to evaluate their acute interactions with circulating blood. In a second study, GDCs were used to treat 34 aneurysms in an additional 17 swine. GDCs were coated with fibronectin, albumin, collagen, laminin, fibrinogen, or vitronectin and then implanted with ions as described above. Bilateral experimental swine aneurysms were embolized with standard GDCs on one side and with ion-implanted, protein-coated GDCs on the other side. The necks of aneurysms were evaluated macroscopically at autopsy, by using post-treatment Day 14 specimens. The dimensions of the orifice and the white fibrous membrane that covered the orifice were measured as the fibrous membrane to orifice proportion. Histopathological evaluation of the neck region was performed by light microscopy and scanning electron microscopy.
RESULTS: Fibronectin-coated, ion-implanted coils showed the greatest acute thrombogenicity (average thrombus weight for standard coils, 1.9 +/- 1.5 mg; weight for fibronectin-coated coils, 8.6 +/- 6.2 mg; P < 0.0001). By using scanning electron microscopy, an intensive blood cellular response was observed on ion-implanted coil surfaces, whereas this was rare with standard coils. At Day 14, greater fibrous coverage of the necks of aneurysms was observed in the ion-implanted coil group (mean fibrous membrane to orifice proportion of 69.8 +/- 6.2% for the ion-implanted coil group, compared with 46.8 +/- 15.9% for the standard coil group; P = 0.0143).
CONCLUSION: The results of this preliminary experimental study indicate that ion implantation combined with protein coating of GDCs improved cellular adhesion and proliferation. Future application of this technology may provide early wound healing at the necks of embolized, wide-necked, cerebral aneurysms.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9179897     DOI: 10.1097/00006123-199706000-00024

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  33 in total

1.  Cerecyte coils in the treatment of intracranial aneurysms: a preliminary clinical study.

Authors:  M Bendszus; L Solymosi
Journal:  AJNR Am J Neuroradiol       Date:  2006 Nov-Dec       Impact factor: 3.825

2.  Histopathologic and immunohistochemical comparison of human, rabbit, and swine aneurysms embolized with platinum coils.

Authors:  Daying Dai; Yong Hong Ding; Mark A Danielson; Ramanathan Kadirvel; Debra A Lewis; Harry J Cloft; David F Kallmes
Journal:  AJNR Am J Neuroradiol       Date:  2005 Nov-Dec       Impact factor: 3.825

3.  Preventing spontaneous thrombosis of experimental sidewall aneurysms: the oblique cut.

Authors:  Yoshikazu Yoshino; Yasunari Niimi; Joon K Song; Shinya Khoyama; Yong Sam Shin; Alejandro Berenstein
Journal:  AJNR Am J Neuroradiol       Date:  2005 Jun-Jul       Impact factor: 3.825

4.  Autologous adipose-derived mesenchymal stem cells improve healing of coiled experimental saccular aneurysms: an angiographic and histopathological study.

Authors:  Aymeric Rouchaud; Waleed Brinjikji; Daying Dai; Yong-Hong Ding; Tina Gunderson; Dana Schroeder; Laurent Spelle; David F Kallmes; Ramanathan Kadirvel
Journal:  J Neurointerv Surg       Date:  2017-01-11       Impact factor: 5.836

5.  Endovascular treatment of experimental aneurysms by use of biologically modified embolic devices: coil-mediated intraaneurysmal delivery of fibroblast tissue allografts.

Authors:  W E Marx; H J Cloft; G A Helm; J G Short; H M Do; M E Jensen; D E Kallmes
Journal:  AJNR Am J Neuroradiol       Date:  2001-02       Impact factor: 3.825

6.  Cyanoacrylate embolization of experimental aneurysms.

Authors:  Jean Raymond; France Berthelet; Anne-Cécile Desfaits; Igor Salazkin; Daniel Roy
Journal:  AJNR Am J Neuroradiol       Date:  2002-01       Impact factor: 3.825

7.  Hydroxyapatite and bFGF Coating of Detachable Coils for Endovascular Occlusion of Experimental Aneurysm.

Authors:  T Shimozuru; T Kamezawa; J Kuratsu; N Sakai; I Nagata; A Kishida; M Akashi; M Matsusaki
Journal:  Interv Neuroradiol       Date:  2004-10-22       Impact factor: 1.610

8.  Experimental polyvinyl alcohol core coil for a drug delivery system.

Authors:  H Matsumoto; T Terada; M Tsuura; T Itakura; A Ogawa
Journal:  Interv Neuroradiol       Date:  2004-10-22       Impact factor: 1.610

9.  Effects of endothelial injury on the rate of thrombus organization in canine carotid arteries occluded with microcoils.

Authors:  T Abruzzo; G G Shengelaia; M Workman; H J Cloft; D A Miller; J E Dion
Journal:  Interv Neuroradiol       Date:  2004-10-22       Impact factor: 1.610

10.  Histological evaluation of endothelial reactions after endovascular coil embolization for intracranial aneurysm. Clinical and experimental studies and review of the literature.

Authors:  T Ozawa; S Tamatani; T Koike; H Abe; Y Ito; Y Soga; H Hasegawa; K Morita; R Tanaka
Journal:  Interv Neuroradiol       Date:  2004-10-22       Impact factor: 1.610

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.